Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Lasser, MD, MBA
Sage Therapeutics
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sage Investigational Site
Birmingham, Alabama, United States
- Sage Investigational Site
Sarasota, Florida, United States
- Sage Investigational Site
Chicago, Illinois, United States
- Sage Investigational Site
Wichita, Kansas, United States
- Sage Investigational Site
New Orleans, Louisiana, United States
- Sage Investigational Site
Boston, Massachusetts, United States
- Sage Investigational Site
Boston, Massachusetts, United States
- Sage Investigational Site
Ann Arbor, Michigan, United States
- Sage Investigational Site
Detroit, Michigan, United States
- Sage Investigational Site
New York, New York, United States
- Sage Investigational Site
Rochester, New York, United States
- Sage Investigational Site
Durham, North Carolina, United States
- Sage Investigational Site
Winston-Salem, North Carolina, United States
- Sage Investigational Site
Philadelphia, Pennsylvania, United States
- Sage Investigational Site
Nashville, Tennessee, United States
- Sage Investigational Site
Dallas, Texas, United States
- Sage Investigational Site
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Mar 2014
- Primary completion
- 3 May 2015
- Completion
- 3 May 2015
- Last update posted
- 15 Sept 2025
- Registered enrollment
- 25
- Registry id
- NCT02052739
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.